Fig. 2From: Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada diseaseLinear regression in best-corrected visual acuity (BCVA) at final visit. LogMAR BCVA for Vogt-Koyanagi-Harada (VKH) disease at 3 months (after treatment) on linear regression among the three groups of homozygotes (HLA-DRB1*04 +/+), heterozygotes (HLA-DRB1*04 +/−), and normal subjects (HLA-DRB1*04 −/−)Back to article page